Ranger Investment Management, L.P. Repligen Corp Transaction History
Ranger Investment Management, L.P.
- $1.37 Billion
- Q1 2025
A detailed history of Ranger Investment Management, L.P. transactions in Repligen Corp stock. As of the latest transaction made, Ranger Investment Management, L.P. holds 222,715 shares of RGEN stock, worth $27 Million. This represents 2.07% of its overall portfolio holdings.
Number of Shares
222,715
Previous 226,067
1.48%
Holding current value
$27 Million
Previous $32.5 Million
12.91%
% of portfolio
2.07%
Previous 2.12%
Shares
31 transactions
Others Institutions Holding RGEN
# of Institutions
495Shares Held
57.6MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$916 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$916 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$615 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$204 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$203 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.71B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....